Impact of angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuria-Reference-Cited by-同舟云学术

Impact of angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuria

Published:2019-08-22 Issue:1 Volume:37 Page:44-52
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Coleman C. I.¹^ORCID,Weeda E. R.²,Kharat A.³,Bookhart B.³,Baker W. L.¹

Affiliation:

1. University of Connecticut School of Pharmacy Storrs CT USA

2. College of Pharmacy at the Medical University of South Carolina Charleston SC USA

3. Janssen Scientific Affairs, LLC Titusville NJ USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14107

Reference38 articles.

1. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

2. Nephropathy in Patients with Type 2 Diabetes Mellitus

3. Drug Treatment for Hypertensive Patients in Special Situations: Diabetes and Hypertension

4. Microalbuminuria in prediction and prevention of diabetic nephropathy in insulin-dependent diabetes mellitus patients

5. Effect of Antihypertensive Therapy on the Kidney in Patients with Diabetes: A Meta-Regression Analysis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antihypertensive treatment for kidney transplant recipients;Cochrane Database of Systematic Reviews;2024-07-31

2. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease;Cochrane Database of Systematic Reviews;2024-04-29

3. Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: A systematic review;Translational Research;2023-11

4. Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study;Rheumatology and Therapy;2023-07-07

5. Treatment patterns of antidiabetic and kidney protective therapies among patients with type 2 diabetes mellitus and chronic kidney disease in Colombia. The KDICO descriptive study;Diabetology & Metabolic Syndrome;2023-07-04